149 related articles for article (PubMed ID: 25405499)
1. Hyperglycemic clamp and oral glucose tolerance test for 3-year prediction of clinical onset in persistently autoantibody-positive offspring and siblings of type 1 diabetic patients.
Balti EV; Vandemeulebroucke E; Weets I; Van De Velde U; Van Dalem A; Demeester S; Verhaeghen K; Gillard P; De Block C; Ruige J; Keymeulen B; Pipeleers DG; Decochez K; Gorus FK;
J Clin Endocrinol Metab; 2015 Feb; 100(2):551-60. PubMed ID: 25405499
[TBL] [Abstract][Full Text] [Related]
2. Twenty-Year Progression Rate to Clinical Onset According to Autoantibody Profile, Age, and
Gorus FK; Balti EV; Messaaoui A; Demeester S; Van Dalem A; Costa O; Dorchy H; Mathieu C; Van Gaal L; Keymeulen B; Pipeleers DG; Weets I;
Diabetes Care; 2017 Aug; 40(8):1065-1072. PubMed ID: 28701370
[TBL] [Abstract][Full Text] [Related]
3. Relationship between glycaemic variability and hyperglycaemic clamp-derived functional variables in (impending) type 1 diabetes.
Van Dalem A; Demeester S; Balti EV; Decochez K; Weets I; Vandemeulebroucke E; Van de Velde U; Walgraeve A; Seret N; De Block C; Ruige J; Gillard P; Keymeulen B; Pipeleers DG; Gorus FK;
Diabetologia; 2015 Dec; 58(12):2753-64. PubMed ID: 26409458
[TBL] [Abstract][Full Text] [Related]
4. One-Hour Oral Glucose Tolerance Tests for the Prediction and Diagnostic Surveillance of Type 1 Diabetes.
Simmons KM; Sosenko JM; Warnock M; Geyer S; Ismail HM; Elding Larsson H; Steck AK
J Clin Endocrinol Metab; 2020 Nov; 105(11):e4094-101. PubMed ID: 32844178
[TBL] [Abstract][Full Text] [Related]
5. Oral Glucose Tolerance Test Measures of First-phase Insulin Response and Their Predictive Ability for Type 1 Diabetes.
Baidal DA; Warnock M; Xu P; Geyer S; Marks JB; Moran A; Sosenko J; Evans-Molina C
J Clin Endocrinol Metab; 2022 Jul; 107(8):e3273-e3280. PubMed ID: 35524749
[TBL] [Abstract][Full Text] [Related]
6. Increasing the accuracy of oral glucose tolerance testing and extending its application to individuals with normal glucose tolerance for the prediction of type 1 diabetes: the Diabetes Prevention Trial-Type 1.
Sosenko JM; Palmer JP; Greenbaum CJ; Mahon J; Cowie C; Krischer JP; Chase HP; White NH; Buckingham B; Herold KC; Cuthbertson D; Skyler JS;
Diabetes Care; 2007 Jan; 30(1):38-42. PubMed ID: 17192330
[TBL] [Abstract][Full Text] [Related]
7. Association of serum microRNAs with islet autoimmunity, disease progression and metabolic impairment in relatives at risk of type 1 diabetes.
Snowhite IV; Allende G; Sosenko J; Pastori RL; Messinger Cayetano S; Pugliese A
Diabetologia; 2017 Aug; 60(8):1409-1422. PubMed ID: 28500393
[TBL] [Abstract][Full Text] [Related]
8. Assessment of insulin resistance in normoglycemic young adults.
Preethi BL; Jaisri G; Kumar KM; Sharma R
Fiziol Cheloveka; 2011; 37(1):118-25. PubMed ID: 21466052
[TBL] [Abstract][Full Text] [Related]
9. Disproportionately elevated proinsulin levels precede the onset of insulin-dependent diabetes mellitus in siblings with low first phase insulin responses. The Childhood Diabetes in Finland Study Group.
Røder ME; Knip M; Hartling SG; Karjalainen J; Akerblom HK; Binder C
J Clin Endocrinol Metab; 1994 Dec; 79(6):1570-5. PubMed ID: 7989457
[TBL] [Abstract][Full Text] [Related]
10. IA-2 autoantibodies predict impending type I diabetes in siblings of patients.
Decochez K; De Leeuw IH; Keymeulen B; Mathieu C; Rottiers R; Weets I; Vandemeulebroucke E; Truyen I; Kaufman L; Schuit FC; Pipeleers DG; Gorus FK;
Diabetologia; 2002 Dec; 45(12):1658-66. PubMed ID: 12488955
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of islet cell antibodies and its correlation with glucose and insulin response to oral glucose tolerance test in 1st degree relatives of insulin dependent diabetes mellitus probands.
Merchant PC; Godse CS; Varthakavi PK; Patel KL; Nihalani KD
J Assoc Physicians India; 1998 May; 46(5):417-23. PubMed ID: 11273280
[TBL] [Abstract][Full Text] [Related]
12. Prediction of Impending Type 1 Diabetes through Automated Dual-Label Measurement of Proinsulin:C-Peptide Ratio.
Van Dalem A; Demeester S; Balti EV; Keymeulen B; Gillard P; Lapauw B; De Block C; Abrams P; Weber E; Vermeulen I; De Pauw P; Pipeleers D; Weets I; Gorus FK;
PLoS One; 2016; 11(12):e0166702. PubMed ID: 27907006
[TBL] [Abstract][Full Text] [Related]
13. Predictive value of intravenous glucose tolerance test insulin secretion less than or greater than the first percentile in islet cell antibody positive relatives of type 1 (insulin-dependent) diabetic patients.
Vardi P; Crisa L; Jackson RA
Diabetologia; 1991 Feb; 34(2):93-102. PubMed ID: 2065854
[TBL] [Abstract][Full Text] [Related]
14. Young age and HLA markers enhance the risk of progression to type 1 diabetes in antibody-positive siblings of diabetic children.
Yamamoto AM; Deschamps I; Garchon HJ; Roussely H; Moreau N; Beaurain G; Robert JJ; Bach JF
J Autoimmun; 1998 Dec; 11(6):643-50. PubMed ID: 9878086
[TBL] [Abstract][Full Text] [Related]
15. The TrialNet Natural History Study of the Development of Type 1 Diabetes: objectives, design, and initial results.
Mahon JL; Sosenko JM; Rafkin-Mervis L; Krause-Steinrauf H; Lachin JM; Thompson C; Bingley PJ; Bonifacio E; Palmer JP; Eisenbarth GS; Wolfsdorf J; Skyler JS; ;
Pediatr Diabetes; 2009 Apr; 10(2):97-104. PubMed ID: 18823409
[TBL] [Abstract][Full Text] [Related]
16. Single Islet Autoantibody at Diagnosis of Clinical Type 1 Diabetes is Associated With Older Age and Insulin Resistance.
Redondo MJ; Sosenko J; Libman I; McVean JJF; Tosur M; Atkinson MA; Becker D; Geyer S
J Clin Endocrinol Metab; 2020 May; 105(5):1629-40. PubMed ID: 31867614
[TBL] [Abstract][Full Text] [Related]
17. Prognostic accuracy of immunologic and metabolic markers for type 1 diabetes in a high-risk population: receiver operating characteristic analysis.
Xu P; Beam CA; Cuthbertson D; Sosenko JM; Skyler JS; Krischer JP;
Diabetes Care; 2012 Oct; 35(10):1975-80. PubMed ID: 22787174
[TBL] [Abstract][Full Text] [Related]
18. Simplifying prediction of disease progression in pre-symptomatic type 1 diabetes using a single blood sample.
Bediaga NG; Li-Wai-Suen CSN; Haller MJ; Gitelman SE; Evans-Molina C; Gottlieb PA; Hippich M; Ziegler AG; Lernmark A; DiMeglio LA; Wherrett DK; Colman PG; Harrison LC; Wentworth JM
Diabetologia; 2021 Nov; 64(11):2432-2444. PubMed ID: 34338806
[TBL] [Abstract][Full Text] [Related]
19. OGTT Metrics Surpass Continuous Glucose Monitoring Data for T1D Prediction in Multiple-Autoantibody-Positive Individuals.
Ylescupidez A; Speake C; Pietropaolo SL; Wilson DM; Steck AK; Sherr JL; Gaglia JL; Bender C; Lord S; Greenbaum CJ
J Clin Endocrinol Metab; 2023 Dec; 109(1):57-67. PubMed ID: 37572381
[TBL] [Abstract][Full Text] [Related]
20. Assessment of insulin sensitivity from measurements in the fasting state and during an oral glucose tolerance test in polycystic ovary syndrome and menopausal patients.
Ciampelli M; Leoni F; Cucinelli F; Mancuso S; Panunzi S; De Gaetano A; Lanzone A
J Clin Endocrinol Metab; 2005 Mar; 90(3):1398-406. PubMed ID: 15598698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
